Shares of Hims & Hers tumble 21% after FDA says semaglutide is no longer in shortage
Related Posts
Tom Lee says this is the worst market overreaction since 2020 pandemic outbreak
The Nasdaq Composite fell more than 3%, while the S&P 500 dropped 1.5% on Monday. Nvidia contributed to the losses, tanking nearly 17%.
Google CEO Pichai struggled to navigate a pressure-filled year
Google CEO Pichai notched some AI wins but struggled to navigate a pressure-filled year.
Palantir drops 10% for worst day since May as investors continue dumping onetime market favorite
The stock notched its fourth straight losing session.